Abstract
Contrast-enhanced ultrasound (CEUS) with quantitative parametric imaging is currently not recommended for the detection of prostate cancer (PCa). Meanwhile, multiparametric magnetic resonance imaging (mpMRI)-targeted biopsy (TBx) has evolved as an alternative to systematic transrectal ultrasound (TRUS)-guided biopsy (SBx). However, mpMRI before first biopsy remains controversial. In this prospective trial, we compared clinically significant (cs)PCa detection rates for MRI-TBx and CEUS-TBx with standard SBx in biopsy-naive men.
Original language | English |
---|---|
Pages (from-to) | e430-e430 |
Number of pages | 1 |
Journal | Journal of Urology |
Volume | 201 |
Issue number | 4S |
DOIs | |
Publication status | Published - 1 Apr 2019 |
Event | 114th American Urological Association Annual Meeting - Chicago, United States Duration: 3 May 2019 → 6 May 2019 http://www.aua2019.org/ |